AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.23 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday ↗

July 12, 2023

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Optimism Improves Ahead Of Inflation Data ↗

July 12, 2023

The CNN Money Fear and Greed index showed some improvement in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed higher on Tuesday ahead of this week’s key inflation data. The...

Via Benzinga

AngioDynamics's Earnings: A Preview ↗

July 11, 2023

Via Benzinga

AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023

June 20, 2023

From AngioDynamics, Inc.

Via Business Wire

Why Shares of AngioDynamics Rose Friday ↗

June 09, 2023

The medical technology company sold some of its assets to pay down its debt.

Via The Motley Fool

Preview: AngioDynamics's Earnings ↗

March 29, 2023

Via Benzinga

Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement ↗

June 09, 2023

Needham analyst Mike Matson reiterated a Buy rating on the shares of Merit Medical Systems, Inc. (NASDAQ: MMSI),

Via Benzinga

AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M ↗

June 09, 2023

AngioDynamics, Inc. (NASDAQ: ANGO)

Via Benzinga

AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million

June 08, 2023

From AngioDynamics, Inc.

Via Business Wire

Top 5 Health Care Stocks That Are Preparing To Pump In Q2 ↗

April 26, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

AngioDynamics to Present at the Needham Virtual Healthcare Conference

April 11, 2023

From AngioDynamics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗

April 17, 2023

Via Benzinga

Wall Street Thinks This Small-Cap Stock Can Double in Value ↗

April 04, 2023

Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months.

Via The Motley Fool

Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher ↗

March 30, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P...

Via Benzinga

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 31, 2023

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 30, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Why AngioDynamics Shares Are Trading Lower Today ↗

March 30, 2023

AngioDynamics (NASDAQ: ANGO) shares are trading lower on Thursday after the company reported worse-than-expected Q3 revenue and reduced its 2023 revenue guidance.

Via Benzinga

US Stocks Open Higher; Dow Jumps 150 Points ↗

March 30, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.48% to 32,874.88 while the NASDAQ rose 0.68%...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 30, 2023

Via Benzinga

AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance

March 30, 2023

From AngioDynamics, Inc.

Via Business Wire

US Stocks Eye Strong Q1 Finish As Futures Point To Higher Open: Jobless Claims, GDP Data In Focus ↗

March 30, 2023

The positive momentum witnessed in recent sessions could spill over into Thursday as the index futures point to a moderately higher opening.

Via Benzinga

AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023

March 13, 2023

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Participate in Three Investor Conferences in March

February 28, 2023

From AngioDynamics, Inc.

Via Business Wire

American Airlines, Morgan Stanley And 2 Other Stocks Insiders Are Selling ↗

February 02, 2023

The Nasdaq jumped by around 2% on Wednesday following the Fed’s rate decision. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Is This Under-the-Radar Growth Stock a Buy? ↗

January 19, 2023

This company is a small player in the steadily growing medtech industry.

Via The Motley Fool

AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance

January 05, 2023

From AngioDynamics, Inc.

Via Business Wire

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

Nasdaq, S&P 500 Futures Edgy Ahead Of Data-Heavy Session — Analyst Says Markets In 'Holding Pattern' In Anticipation Of Q4 Results, CPI Print ↗

January 05, 2023

U.S. stocks look set to open Thursday’s session on a nervous note, potentially reversing the gains from the previous session.

Via Benzinga

Earnings Scheduled For January 5, 2023 ↗

January 05, 2023

Companies Reporting Before The Bell • Schnitzer Steel Indus (NASDAQ:SCHN) is expected to report quarterly loss at $0.45 per share on revenue of $602.73 million.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.